No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida
Ph: 561.316.3330

HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Category: CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Sedana Medical Completes Patient Recruitment...

"The completion of INSPiRE-ICU 2 concludes Sedana Medical´s clinical trials in the United States. Running this study together with esteemed clinical investigators from highly ranked academic centers such as Columbia, the Harvard-affiliated medical center Beth Israel Deaconess Medical Center and many others has been very exciting and rewarding. Many investigators from the participating sites have been excited to be part of our pioneering studies. The bedside experience in the studies has generated a lot of interest in using inhaled sedation in US practice, which we hope will be possible soon," said Peter Sackey, Chief Medical Officer of Sedana Medical.

Viz.ai and UTMB Announce Collaboration...

“Patient enrollment is the most time-consuming and costly aspect of the clinical trial process,” said Prem Batchu-Green, Vice President of Clinical at Viz.ai. “By deploying Viz.ai for the CHESS study, we are not only reducing the manual burden of patient identification on research staff but also improving SDH detection and workflow as well as increasing SDH awareness, physician engagement, clinical specialist attendance, and case collaboration.”

Sedana Medical Completes Patient Recruitment for its Clinical Program in the US

"The completion of INSPiRE-ICU 2 concludes Sedana Medical´s clinical trials in the United States. Running this study together with esteemed clinical investigators from highly ranked academic centers such as Columbia, the Harvard-affiliated medical center Beth Israel Deaconess Medical Center and many others has been very exciting and rewarding. Many investigators from the participating sites have been excited to be part of our pioneering studies. The bedside experience in the studies has generated a lot of interest in using inhaled sedation in US practice, which we hope will be possible soon," said Peter Sackey, Chief Medical Officer of Sedana Medical.

Intact Vascular Announces Positive 1-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

The one-year results, which successfully demonstrated sustained improvement in Rutherford category, toe-brachial index (TBI) and quality-of-life metrics following management of patients with post-PTA dissection with the Tack Endovascular System® (4F), in conjunction with excellent limb salvage and amputation free survival rates.

Dayzz Sleep App Announces Publication of the Findings From Clinical Trial to Validate Its Sleep Assessment Machine Learning Engine

The clinical trial was conducted in collaboration with the Johns Hopkins Center for Interdisciplinary Sleep Research and Education.

EndoGastric Solutions Advises A New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology

The article, authored by Glenn Ihde, MD, a board-certified general surgeon at the Matagorda Medical Group in Bay City, Texas, provides an overview of current best practices with respect to TIF 2.0 as a stand-alone procedure as well as in conjunction with hiatal hernia (HH) repair.

iBiopsy®: Show Promising Results on a Preliminary Study

The iBiopsy® imaging biomarker discovery platform, which integrates advanced technologies in artificial intelligence has produced these results on one of the three indications on which it is positioned.

ABRE Clinical Study Meets Primary Safety and Effectiveness Endpoints

The ABRE Study is a prospective, interventional, single-arm, multi-center, worldwide study, which included 200 subjects with symptomatic iliofemoral venous outflow obstruction from 24 sites throughout the U.S. and Europe.

Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus

SAFER Sample Collection Kit is registered as a Class A medical device with the Health Sciences Authority of Singapore and is an easy-to-use saliva collection kit that comes with a bottle of stabilization fluid to be mixed with the sample at the point of collection, keeping viral RNA stable at room temperature for up to one week.

Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions

Omnipod 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless smartphone-controlled automated insulin delivery system for people living with diabetes.

Reflow Medical Enrolls First Patients in the DEEPER LIMUS Study of the Temporary Spur Stent System

Reflow Medical notes the OUS single-center clinical trial (NCT04162418) is expected to enroll up to 30 participants and last approximately six months.

By using this website you agree to accept Medical Device News Magazine Privacy Policy